Follow The Filings

ASST Strive

Strive earnings company data as of 4:48 AM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 9 Nov EPS 3.44 — —
Rev — — —

Insider trades

Open-market buys and sales by ASST's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ASST insider trades
  • $1.3M bought by 4 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Pierre Rochard Director
    Buy
    $199K 15,900 shares at $12.54 New stake
    Traded Aug 14 Filed Aug 18
  2. Benjamin Pham CFO
    Buy
    $115K 14,114 shares at $8.15 New stake
    Traded Feb 17–18 Filed Feb 19
  3. Brian Logan Beirne Chief Legal Officer
    Buy
    $100K 11,500 shares at $8.73 +311% to stake
    Traded Feb 13 Filed Feb 17
  4. Matthew Ryan Cole CEO
    Buy
    $459K 500,000 shares at $0.9200 +190% to stake
    Traded Jan 13 Filed Jan 14
  5. Matthew Ryan Cole CEO
    Buy
    $416K 515,195 shares at $0.8100
    Traded Dec 15, 2025 Filed Dec 16, 2025

Also filed in the last 12 months, not counted as buying or selling: 9 option exercises, 6 sales to cover taxes, 2 stock grants, 1 gift, and 1 trade in other securities.

SEC filings

Recent issuer filings from EDGAR, 23 shown.

Filed Form Detail Links
8-K 8.01
8-K 3.03,5.03,8.01,9.01
8-K 8.01
424B5 FORM 424B5
8-K 1.01,8.01,9.01
8-K 8.01
SCHEDULE 13D/A —
8-K 8.01,9.01
424B5 FORM 424B5
8-K 3.03,5.03,8.01,9.01
8-K 8.01
8-K 8.01
8-K 8.01
8-K 8.01
8-K 8.01
8-K 8.01
8-K 8.01
8-K 8.01
SCHEDULE 13D/A —
8-K 8.01
8-K 8.01
SCHEDULE 13G/A —
8-K 8.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.